Brokerages forecast that Electromed, Inc. (NASDAQ:ELMD) will announce earnings per share (EPS) of $0.01 for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Electromed’s earnings. Electromed posted earnings of $0.02 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 50%. The business is scheduled to announce its next quarterly earnings report after the market closes on Tuesday, November 12th.
According to Zacks, analysts expect that Electromed will report full year earnings of $0.28 per share for the current year. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Electromed.
Electromed (NASDAQ:ELMD) last released its quarterly earnings results on Tuesday, August 27th. The company reported $0.13 earnings per share (EPS) for the quarter. The business had revenue of $8.60 million for the quarter.
Electromed stock traded down $0.18 during mid-day trading on Thursday, reaching $6.72. 4,200 shares of the company’s stock traded hands, compared to its average volume of 12,991. Electromed has a 12-month low of $4.75 and a 12-month high of $7.25.
Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.
Featured Article: What are the Different Types of Leveraged Buyouts?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.